Remission rate of implant-related infections following revision surgery after fractures by Al-Mayahi, Mohamed et al.
ORIGINAL PAPER
Remission rate of implant-related infections following revision
surgery after fractures
Mohamed Al-Mayahi & Michael Betz & Daniel A. Müller & Richard Stern &
Phedon Tahintzi & Louis Bernard & Pierre Hoffmeyer & Domizio Suvà & Ilker Uçkay
Received: 12 June 2013 /Accepted: 18 August 2013 /Published online: 20 September 2013
# Springer-Verlag Berlin Heidelberg 2013
Abstract
Purpose In contrast to a large amount of epidemiological data
regarding the incidence of implant infections after fracture
management, surprisingly few have been published
concerning the success of their treatment.
Methods This was a single-centre cohort study at Geneva
University Hospitals from 2000 to 2012 investigating the
remission rates of orthopaedic implant infections after fracture
repair and associated variables.
Results A total of 139 episodes were included: There were 51
women (37%) and 28 immunosuppressed (20%) patients with
a median age and American Society of Anaesthesiologists
(ASA) score of 51 years and 2 points, respectively. The
infected implants were plates (n =75, 54 %), nails (24,
17 %), wires (20), screws (10), cerclage cables or wires (3),
hip screws (4) or material for spondylodesis (3). A pathogen
was identified in 135 (97 %) cases, including Staphylococcus
aureus (73, 52 %), coagulase-negative staphylococci (20),
streptococci (7) and 19 Gram-negative rods. All patients
underwent antibiotic treatment, and 128 (92 %) remained in
remission at a median follow-up time of 2.6 years (range one to
13 years). In multivariate logistic regression analysis, the plate
infections were significantly associated with lower remission
rates [65/75, 87 %, odds ratio (OR) 0.1, 95 % confidence
interval (CI) 0.01–0.90]. No associations were found for gen-
der, age, immune status, ASA score, additional surgical inter-
ventions (OR 0.4, 95 % CI 0.1–4.1) or duration of antibiotic
treatment (OR 1.0, 95 % CI 0.98–1.01).
Conclusions Among all infected and removed orthopaedic
implants, plates were associated with slightly lower remission
rates, while the overall treatment success exceeded 90 %. The
duration of antibiotic therapy did not alter the outcome.
Keywords Implant-related infection . Implant removal .
Antibiotic therapy . Remission rate . Post-traumatic
osteomyelitis
Introduction
There is a large amount of epidemiological data regarding the
incidence (approximately 1–5 %) [1] of orthopaedic implant
infections after fracture repair. In contrast, surprisingly little
has been published concerning the success of their treatment
[1]. Expert recommendations pertain to other osteoarticular
infections and advocate at least one surgical drainage, implant
removal if feasible and concomitant antibiotic therapy until
osseous consolidation or for six weeks post implant removal
[2–4]. This is the case even though implant-associated infec-
tions are conceptually different from other orthopaedic infec-
tions. They usually lack the ongoing presence of an implant
(usually removed and which hampered infection cure [1, 2]),
and they usually do not have sequestra, the hallmark of
chronic osteomyelitis.
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In the literature the duration of antimicrobial administration
after implant removal, and the variables associated with re-
mission, have been investigated thus far for arthroplasty-
associated infections [5–7], but less for chronic osteomyelitis
cases [3, 8], and even less for fracture device-associated
infections, the latter often with fewer than 30 episodes includ-
ed per publication [9–13]. Theoretically, complete implant
removal is the essential part of treatment, and therefore a
relatively short period of antibiotic administration might be
sufficient for sterilisation of superficial bone layers adjacent to
the implant. In this single-centre cohort study, we investigated
remission rates of orthopaedic implant infections after
fracture management and associated variables, with an
emphasis on the duration and form of antibiotic treat-
ment. We think that antibiotic therapy concomitant with
surgery might be significantly reduced to some few
weeks in an oral form. We did not address risk factors
for infection occurring after primary osteosynthesis [4]
or the incidence of infections after elective implant removal
for mechanical reasons.
Patients and methods
Setting and data collection
The Orthopaedic Department of Geneva University Hospitals
has 132 acute care beds (24 on the Septic Ward). Several
dedicated infectious diseases (ID) consultants (since the year
2000) have established a number of databases regarding or-
thopaedic infections as approved by our local hospital Ethics
Committee. Usually, infected fracture devices are treated with
a combined medical and surgical approach with little variation
at the discretion of the treating surgeon and physician. If bone
is consolidated, all infected fracture devices are removed
completely. In cases of non-consolidated bone, transient exter-
nal fixation is applied. Debridement involves thorough remov-
al of all infected tissue, including bone layers, to the maximum
extent possible. After nail removal, the intramedullary cavity
undergoes thorough reaming. The decision for surgical re-
intervention for the initial treatment depends on clinical pa-
rameters and the surgeon’s individual opinion. Normally, a
second look is routinely performed. After surgery, infected
patients are followed up actively by the corresponding surgeon
and the ID physician for at least one year. Given that Geneva
University Hospitals are the only public hospital in the area,
many patients return for various reasons later in their lifetime
and are reassessed for all former diseases by physicians or
surgeons of the hospital (e.g. infection active or not). Thus,
the follow-up time for this study involves an active
evaluation by a surgeon or physician, who however
does not need to be the same person in charge during
infection.
Patients
A total of 139 episodes of implant-related infections were avail-
able for further analysis with a median hospital length of stay of
18 days (range four to 139 days). A minority of patients were
women (51, 37 %) or immunosuppressed (28, 20 %), the latter
mostly secondary to diabetes mellitus, Child’s class C cirrhosis,
dialysis or active cancer or immunosuppressive therapy. The
median age and American Society of Anaesthesiologists (ASA)
scores were 51 years (range 17–93 years) and 2 points (range 1–
4 points), respectively. The median time delay between initial
implant insertion and the first clinical signs of infection was
five months (range 0–240 months).
The infected implants involved plates (n =75, 54 %), nails
(n =24, 17 %), wires (20), screws (10), cerclage cables or
wires (3), hip screws (4) or material for spondylodesis (3).
Twelve plates revealed one additional material such as screws
or wires. No hardware was embedded in antiseptics, antimi-
crobials or silver. The implants were localised at different
sites, including lower extremity (n =115), upper extremity
(15), spine (4), pelvis (3), and clavicle (2). A pathogen was
identified in 135 (97%) cases. Staphylococcus aureus was the
most frequent organism (n =73, 52 %, of which 15 were
resistant to methicillin), followed by coagulase-negative staph-
ylococci (20), streptococci (7) and 19 Gram-negative rods, of
which seven were Pseudomonas aeruginosa . Polymicrobial
infection occurred in 24 episodes (17 %).
Study questions
We investigated two study questions: (1) the incidence of
subsequent osteomyelitis after treatment of an infected implant
and (2) the variables associated with treatment success or
failure. We collected 48 variables per episode on an Excel™
spreadsheet. All osteomyelitis databases were cross-referenced
with the Hospital’s Coding Office files for patient identifica-
tion. All eligible patients with non-arthroplasty-associated or-
thopaedic implant infections from January 2000 to December
2012 were included. The diagnosis of infection was based
upon the presence of intraoperative pus, together with
clinical signs of infection (new onset of pain, fever,
discharge and/or radiographic signs of implant loosen-
ing). The identification of the infecting organism re-
quired that the same pathogen be present in at least
two intraoperative samples. Remission was defined as
the absence of any clinical, laboratory or radiological signs of
recurrence after a minimum follow-up of one year. Only the
first episode of the same infection was included and recurrent
episodes were eliminated from further analysis. Other exclu-
sion criteria were as follows: insufficient data, orthopaedic
patients with prosthetic joint infections or non-orthopaedic
implant infections such as vascular implants or pacemakers
[14], chronic osteomyelitis cases marked by sequestrum or
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involucrum, absence of surgical debridement in the operating
room (e.g, very ill patients or superficial implant removal on
the ward), amputation for cure or an insufficient follow-up.
The latter was defined as follow-up in another hospital or for
less than one year after treatment. Moreover, we excluded
patients with septic non-unions, those requiring major soft
tissue coverage and patients requiring external fixation after
internal implant removal.
Statistical analyses
Group comparisons were performed using Pearson’s χ2, Fish-
er’s exact or the Wilcoxon rank sum tests, as appropriate. An
unmatched logistic regression analysis determined associations
with the outcome “remission”. Independent variables with a p
value ≤0.30 in univariate analysis were introduced stepwise in
the multivariate analysis, while surgical and antibiotic-related
variables were included in every case. We included five to ten
outcome events per predictor variable [15]. Key variables were
checked for confounding, colinearity and interaction, the latter
by Mantel-Haenszel estimates and interaction terms. Age, du-
ration of antibiotic administration and time delay between
initial implant insertion and subsequent infection were
analysed as continuous and categorised variables; p values
≤0.05 (all two-tailed) were significant. Stata™ software (ver-
sion 9.0, StataCorp, College Station, TX, USA) was used.
Results
Therapy and remissions
All episodes underwent combined surgical and antibiotic
treatment, and 128 remained in remission (92 %) after a
median follow-up time of 2.6 years (range one to 13 years)
(Table 1). The 11 recurrences occurred at the same site with the
same pathogen between six weeks and three years after the first
treatment. There were no arthrodeses, amputations or partial
implant removals performed. Thus, if an implant was removed,
it was complete. The majority of episodes had two interven-
tions (second look in 114 cases, 82%), and only a minority had
a single surgical intervention (25 cases). None had three or
more interventions. Among all infected materials, 20 were left
in place: 11 plates, seven nails, one dynamic hip screw and one
screw. Retrospectively, there were no differences in the pro-
portion of material types and the decision for implant removal
or retention, with one potential exception: The subgroup
“screw, cerclage and wire” witnessed a tendency to more
removal [odds ratio (OR) 0.16, 95 % confidence interval (CI)
0.1–1.1] but was not statistically significant (29/130 vs 1/20;
Fisher’s exact test, p =0.07), whereas the number of surgical
interventions for this group was the same compared to other
larger implants (26/144 vs 4/25; Fisher’s exact test, p =0.60).
Antibiotic therapy varied considerably. We noted 72 differ-
ent regimens with a median duration of total and parenteral
antibiotic administration of 42 and four days, respectively.
Episodes with or without implant removal had a similar dura-
tion of total antibiotic therapy (Wilcoxon rank sum test, median
42 vs 53 days, p =0.27) as were patients with or without a
second look (Wilcoxon rank sum test, median 42 vs 42 days,
p =0.58).
Group comparison and univariate analysis
The groups of patients with and without remission did not
differ significantly (Table 1), with the exception of
pseudomonal infections and plates. In univariate analysis
targeting the outcome “remission”, plate infection yielded a
lower remission rate compared to all other implants (OR 0.1,
95 % CI 0.01–0.82, p =0.03). Of note, plate-associated infec-
tions showed no interaction (effect modification) when strat-
ified according to staphylococcal, pseudomonal or tibial in-
fections. Likewise, plate-related infections failed to show
another outcome when stratified upon retention or retention
vs removal cases (Mantel-Haenszel estimates, all p >0.45).
Multivariate adjustment
Due to differences in crude group comparisons (Table 1), a
multivariate logistic regression analysis adjusted for case mix
(Table 2). The only significantly associated variables remaining
were once again plate infection (OR 0.1, 95 % CI 0.01–0.90)
and pseudomonal infection (OR 0.1, 95 % CI 0.01–0.81)
(Table 2). No associations were found for gender, age, immune
status, ASA score, additional surgical interventions or modali-
ties concerning antibiotic therapy. Compared to 42 days or less
of total post-operative antibiotic administration, 43–63 days or
over 63 days were equivalent in terms of remission. Likewise,
the duration of the initial parenteral administration route did not
alter the outcome (Table 2). Of note, the goodness-of-fit test was
insignificant (p =0.168) and the receiver-operating char-
acteristic (ROC) curve value was 0.86 (95 % CI 0.74–
0.98), highlighting a more than acceptable performance
of our final model.
Discussion
In our case–control study, remission rates of combined surgi-
cal and medical treatment of established implant infections
after fracture management (128/139, 92 %) were significantly
higher than for the treatment of chronic osteomyelitis [7] or
arthroplasties [9, 10], with remission rates ranging between 75
and 90 % in the literature [4]. Our remission rate is also higher
than the 73 % published regarding young healthy individuals
with ankle fractures [14] or the 72 % among 25 early
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staphylococcal infections following rigid internal fixation [9].
We cannot explain the exact reasons for the difference
inasmuch as the duration of our antibiotic treatment was much
shorter, while the distribution of the pathogens, the duration of
follow-up and surgical approach were shared with other au-
thors [5, 16]. It may be that our study population had a higher
proportion of screws and wires. Screws and wires tended to be
more easily removed than other implants with potentially
higher remission rates, but the number of surgical debride-
ments was equal when compared to larger implants.
In both univariate and multivariate analyses, plate-related
and pseudomonal infections were formally associated with a
worse outcome [17]. However, our finding has to be
interpreted with caution. Two recurrences among seven infec-
tions are a very small base for proving the difficult treatment
for P. aeruginosa . At best, this is only giving a little hint that
the experiences about the difficulties of treatment are support-
ed. Theoretically, the Gram-negative rod P. aeruginosa
is known to be particularly difficult to eradicate from
osteoarticular and prosthetic joint tissue due to its extended
biofilm-producing capacities, its natural resistance to a variety
of antimicrobial agents and development of rapid resistance
even during ongoing therapy. In the literature, osteoarticular
infections due to P. aeruginosa regularly yield higher failure
rates as compared to Gram-positive microorganisms, even if
the difference is not always statistically significant [18–20].
In contrast, plate-associated infections revealed more ro-
bust statistical evidence to be associated with lower remission
rates, for which the exact reason remains unknown. In our
study, plates accounted for the largest part of infected fracture
implants and were not particularly associated with
pseudomonal or staphylococcal infections or those due to
other germs. We equally were unable to find a link with a
particular localisation site, such as ankle or distal tibia [21]. To
the best of our knowledge, this finding has not been investi-
gated in the literature. Indeed, when it comes to the evaluation
of treatment success most publications regarding implant in-
fections after fracture management have only looked for risk
factors for infection or provided results for all implant material
without distinction. Theoretically, one might predict that nails
with an internal surface infected inside the bone would be
associated with more treatment failures. On the other hand,
there exists a well-known procedure for nails to minimise
recurrence of infection: medullary reaming. For plates there
is no such safe procedure known. They could be the real
reason for the difference. Moreover, plates are removed with-
out “reaming” of adjacent bone surface, and removal involves
more soft tissue damage, a point which has already been
mentioned [21]. Perhaps the extent of the soft tissue damage
and wound healing problems might explain our findings.
All other variables were not significantly associated with
recurrent infection. Age, immunosuppression, ASA score,
staphylococcal infection or time delay from the time of inser-
tion of the hardware did not play a role. Of note, supplemen-
tary surgical debridements and the duration and route of
concomitant antibiotic therapy equally failed to alter the
Table 1 Group comparison with
treatment failure and success of
infected orthopaedic implants af-
ter fracture (non-arthroplasty)
a Only p values ≤0.05 (two-tailed)
are displayed, χ2 or Fisher’s exact
test
b Diabetes mellitus, immunosup-
pressive therapy, dialysis, Child’s
class C cirrhosis, active cancer
Failure Comparison Remission
n =139 n=11 p valuea n =128
Female gender 5 (45 %) 46 (36 %)
Age group≤40 years 5 (45 %) 45 (35 %)
Age group 41–62 years 2 (18 %) 40 (31 %)
Age group>63 years 4 (36 %) 43 (34 %)
Immunosuppressionb 2 (18 %) 26 (20 %)
Plate-related infection 10 (91 %) 0.010 65 (51 %)
Nail-related infection 1 (9 %) 23 (18 %)
Screw, cerclage and wire 0 (0 %) 30 (23 %)
Implant on lower extremity 10 (91 %) 101 (80 %)
Tibial implant infection 5 (45 %) 64 (50 %)
Implant on upper extremity 1 (9 %) 13 (10 %)
Due to S. aureus 4 (36 %) 69 (54 %)
Due to P aeruginosa 2 (18 %) 0.038 5 (4 %)
Second surgical look 9 (82 %) 105 (82 %)
Implant retention (vs removal) 3 (27 %) 17 (13 %)
Total antibiotic therapy<6 weeks 3 (27 %) 75 (59 %)
Total antibiotic therapy 6–9 weeks 2 (18 %) 8 (6 %)
Total antibiotic therapy>9 weeks 6 (55 %) 45 (35 %)
Parenteral antibiotic therapy≤4 days 5 (45 %) 57 (45 %)
Parenteral antibiotic therapy>4 days 6 (55 %) 71 (55 %)
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outcome. Compared to 42 days or less of post-operative antibi-
otic administration, 43–63 days or more than 63 days were
equivalent in terms of preventing subsequent osteomyelitis.
These findings are not surprising. The adequate administration
route and the duration of antibiotic agents in implant infections
are not based on randomised trials or other forms of evidence.
They rely on expert opinion with some indirect information
from past animal studies or in vitro experiments [3, 4]. Tradi-
tionally, a six- to 12-week course of antibiotic therapy is recom-
mended [5, 9, 10, 13, 16], of which the first two to four weeks
are usually given intravenously [1, 11]. This general recommen-
dation has been continuously challenged in recent years in
favour of shorter antibiotic administration time with decreased
parenteral regimen [7, 10, 11]. One further result of interest was
the influence of implant retention on remission rates. In our
study lack of implant removal did not significantly influence
remission at a one-year follow-up. There is a debate in the
literature whether infected implants after fracture management
should always be removed. Although most experts would ad-
vocate their removal, others report up to 70 % success with the
hardware in place when bone union was achieved [16, 18].
In conclusion, our retrospective study revealed that plates
(and maybe P. aeruginosa ) were associated with lower
remission rates in orthopaedic implant infections after fracture
repair. Both variables are difficult to influence since P.
aeruginosa escapes the majority of perioperative antibiotic
agents [8] and the choice of plates cannot always be replaced
by other implants in daily practice. Even with these two
variables our treatment success already exceeded 90 %
in the first instance, almost independently of whether
the implant was removed or retained. It might be that
implant-related infections differ from chronic osteomye-
litis or infected artificial joint replacements inasmuch
as bacteria usually lie beneath the foreign body without addi-
tional bone alterations in terms of sequestra, fistula or involu-
crum [3]. Therefore, the removal of the infected foreign body
and adjacent bone layers [1] may usually be sufficient for
remission. Concomitant antibiotic therapy might require
shorter courses than generally recommended for all
osteoarticular infections. These presumptions need confirma-
tion in other trials.
Our study has the following limitations: (1) It only includes
adults and comes from a single institution in a high-income
country, aspects that might limit extrapolation of its findings.
(2) Although many variables have been accounted for,
others remain unanalysed, such as smoking status [17,
Table 2 Associations with con-
tinuous remission after 1 year
Results are displayed as OR
(95 % CI). Variables in boldface
are statistically significant (two-
tailed p value <0.05)
a Diabetes mellitus, immunosup-
pressive therapy, dialysis, Child’s
class C cirrhosis, active cancer
b ASA score, continuous variable
c Implant not removed, only
debridement
d Second look or debridement
Number Univariate analysis Multivariate analysis
Female gender n =51 0.7 (0.2–2.3) 0.6 (0.1–2.9)
Age (continuous variable) 1.0 (0.98–1.04) 1.0 (0.96–1.06)
Age≤40 years n =50 1 n.a.
Age 40–63 years n =42 2.2 (0.4–12.1) n.a.
Age >63 years n =47 1.2 (0.3–4.7) n.a.
Immunosuppressiona n =28 1.1 (0.2–5.6) 0.9 (0.1–6.9)
ASA scoreb 1.2 (0.5–2.7) 0.9 (0.2–2.8)
Delay implantation-infection 1.0 (0.98–1.06) 1.0 (0.97–1.09)
≤ 5 months n =71 1 1
> 5 months n =68 0.5 (0.1–1.9) 0.5 (0.1–2.5)
Infection due to S. aureus n =73 2.0 (0.6–7.3) n.a.
Coagulase-negative staphylococci n =20 1.7 (0.2–14.4) n.a.
Pseudomonas spp. n=7 0.2 (0.03–1.07) 0.1 (0.01–0.81)
Tibial implants n =69 1.2 (0.3–4.1) n.a
Upper extremity implants n =15 1.1 (0.1–9.6) n.a
Plates n =75 0.1 (0.01–0.82) 0.1 (0.01–0.90)
Nails n =24 2.2 (0.3–18.0) n.a.
Total antibiotic therapy (continuous variable) 1.0 (0.98–1.01) 1.0 (0.98–1.01)
≤42 days n =78 1 1
43–63 days n =10 0.2 (0.1–1.1) 0.1 (0.1–2.5)
> 63 days n =51 0.3 (0.1–1.3) 0.2 (0.1–1.1)
Parenteral therapy (continuous variable) 1.0 (0.97–1.04) 1.0 (0.96–1.06)
≤4 days n =62 1 1
> 4 days n =77 1.0 (0.3–3.6) 0.9 (0.2–4.1)
Implant retainedc n =20 2.4 (0.6–10.1) 4.6 (0.5–45.0)
Second lookd n =114 1.0 (0.2–5.0) 0.8 (0.1–4.1)
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21], serum albumin values [10, 16], hypothyroidism [12],
arteriosclerosis [12] and co-morbidity indexes [16] other than
the ASA score. (3) The indication for implant removal was
influenced by the surgeon and the previous complaints of the
patients. While implant removal upon infection in consolidat-
ed bone does not provoke much discussion, implant removal
without infection or wound dehiscence remains controversial
in the current literature [19, 21]. Hence, for the first part of our
study the low incidence of post-removal osteomyelitis might
be biased by young and healthy trauma patients. They harbour
fewer risks for surgical site infections [4] than elderly patients
with co-morbidities who are not undergoing implant removal
if they are not obliged to do so. (4) Follow-ups may have been
missed in patients who were treated elsewhere after their
initial surgery. However, given that the Geneva University
Hospital is the largest and only public hospital in the area
we consider this selection bias to be minimal. (5) The mini-
mum follow-up time was one year. In the current literature on
arthroplasty infection, this delay has been arbitrarily set at one
to two years [10]. In contrast, classic chronic osteomyelitis can
recur after 40 years [22] and a consensus is more difficult to
establish. Therefore, the required minimum follow-up time
remains unknown for cases of osteomyelitis without implants,
let alone for implant-induced osteomyelitis after the removal
of all of the foreign material, as in our study. The existing
literature in this area yields follow-up times of less than
12 months [10]. (6) We excluded patients with septic non-
unions, such as those requiring external fixation after the
removal of the internal implant. These patients may form a
substantial part of all implant-related infections, for which the
surgical approach is complex and highly individualised [11].
(7) It is possible that patients who appeared less ill clinically,
regardless of co-morbidities, received a shorter course of
antibiotic therapy. Our cohort study cannot compete with
randomised trials when it comes to upgrading of evidence.
We emphasise that our study was purely epidemiological and
not interventional. This potential bias reinforces the need for
randomised studies.
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